CMCMTAShowing 0 of 3 quarters
Position history for
GEODE CAPITAL MANAGEMENT, LLC's holdings in Clementia Pharmaceuticals Inc.
No. Geode Capital Management exited its CMTA (Clementia Pharmaceuticals) position in Q2 2019. Its Q1 2019 13F listed 41,041 shares worth $1.1M. Geode Capital Management already held CMTA in its Q4 2018 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of CMTA: BAKER BROS. ADVISORS LP, Alyeska Investment Group, L.P., TUDOR INVESTMENT CORP ET AL, DRIEHAUS CAPITAL MANAGEMENT LLC, FEDERATED HERMES, INC.